Navigation Links
Over 600 Surgeons Certified to use TruFUSE(R) to Treat Back Pain Sufferers
Date:11/27/2007

Study Indicates 90%+ Success Rate...

CLEARWATER, Fla., Nov. 27 /PRNewswire/ -- minSURG Corporation, a wholly- owned subsidiary of Orthopedic Development Corporation, announced today that it has certified over 600 surgeons in its TruFUSE spine fusion technique.

Over 400 spine surgeons were trained in the basic technique at the North American Spine Society (NASS) convention in Austin, TX last month.

"We believe that this milestone is a reasonable predictor that TruFUSE has the potential to achieve broad acceptance as an early stage surgical solution for back pain sufferers," said James Doulgeris, minSURG's president and CEO.

To support the increase in surgeon users, minSURG has added 21 new domestic regional spine distributors with over 300 additional sales representatives as of today, providing almost complete coverage in the U.S.

"We believe that refinements in the technique and instrumentation provide reliable results with minimum risk and recovery time for patients. That, in conjunction with excellent results from our first study prompted us to release TruFUSE for general distribution in the U.S.," Doulgeris continued.

The TruFUSE minimally invasive back pain alternative uses two small cork- shaped dowels, called allografts, made from human bone, to stop painful spinal facet joints from moving. The dowels are inserted with minimally invasive, minimally destructive techniques between facet joints in the back to stop movement and pain. The TruFUSE technique fills the large void between traditional non-surgical pain management and major surgery.

A retrospective chart review of 81 patients was performed revealing good to excellent pain relief in more than 90% of patients at six weeks postoperatively. Fewer than 5% of patients following up at three months continued to complain of severe pain. The most frequently encountered complication relates to dowel migration, which was observed in 8.6% of patients. Only one of the seven migration cases required revision surgery for recurrence of back pain. There were no serious complications noted.

TruFUSE represents a new surgical option for many back pain sufferers who do not yet qualify for major surgery. It may be used to treat a variety of back problems, including augmentation of other procedures for any location from C2-C3 to L5-S1. Compared to many existing methods, TruFUSE is generally less invasive, less destructive, less complicated, less expensive and subjects the patients to relatively minimal risk.

TruFUSE has been used on select patients since March 2006, and went into limited distribution in August 2006.

For more information on TruFUSE, please visit the Web site at http://www.trufuse.com or call (813) 318-0565 ext. 216.


'/>"/>
SOURCE minSURG Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Surgeons Remove Gallbladder Through Vagina
3. CRH Medical to exhibit at American College of Surgeons Annual Clinical Congress
4. Cosmetic Surgeons Gather in Dubai for World Congress, Hospital Opening
5. Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
6. Patients should ask surgeons about using honey to heal wounds
7. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
8. Survey shows gender differences are factor when surgeons in training choose a subspecialty
9. American College of Surgeons Comments on JAMA Article on Surgeon Shortage
10. Holiday Hand Safety 101: Hand Surgeons Offer Tips for a Safe Carving Season
11. Verdict One Releases Directory of Board Certified Attorneys for Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: